Go further to improve quality

Older Hispanic woman lifting weights in living room

We know you're dedicated to improving health quality outcomes. At Quest Diagnostics, we are continuously developing new solutions that will help you find the insights you need to meet or exceed your goals.

 

Develop clinical laboratory-focused strategies to improve quality

Clinical labs and their data can be a valuable resource for health plans seeking to improve quality outcomes and quality measurement performance. Laboratory partnerships can assist in tracking, measuring, and improving quality across a member’s health journey, spanning from well and episodic care to chronic and acute illness. Learn more in the white paper “Proactive strategies to improve quality outcomes and quality metric performance through laboratory partnerships.”

 

Read the white paper

Data Diagnostics Sample Report
View a Data Diagnostics sample report here.

Visibility helps to improve quality

Introducing Data Diagnostics™

Data Diagnostics is a suite of hundreds of real-time, patient-specific data analyses that can be ordered on demand by clinicians at the point of care within existing workflows. Data Diagnostics helps clinicians identify and address gaps in care, risk, utilization, and medical history and supports improvement in clinical and quality outcomes and financial performance across the healthcare community in real time.

Analytic insights for Health Plan Administrators

Improve HEDIS Scores and Star Ratings

MediCheck™, our clinical risk assessment program, can help maximize your resources, close gaps in care, improve quality outcomes and attain bonus payments. This comprehensive solution helps improve discovery, identification and documentation of member medical conditions with an industry-leading health outreach team and convenient in-home phlebotomy visits to help you to stay on target with your quality reporting deadlines.

Improving health and quality outcomes

Colorectal cancer screening that makes a difference

Improve early detection and survival rates of colorectal cancer with Insure®FIT™—easy, convenient and cost-effective in-home screening that increases compliance with testing guidelines.

Monitor prescription drug misuse

Prescription drug misuse and noncompliance are growing problems, impacting productivity, outcomes and healthcare spend. Our prescription drug monitoring services provide efficient and reliable ways to detect drug diversion, abuse, misuse and patient noncompliance.

Meet population needs through custom screening programs

Target gaps in care and improve quality ratings. Our custom screening programs provide proactive screening and early identification for a number of chronic conditions to support wellness initiatives and provide a better understanding of members' current health and future risks. With more than 7,000 mobile examiners and 2,200 patient service centers, we can help you map your population’s health so you can intervene earlier.

Access innovation

Take advantage of cutting-edge science

Quest helps you diagnose disease earlier to improve health outcomes. Leading the way in advancing science, our achievements include innovative tests for cancer, infectious disease and more.
 

 

Groundbreaking Innovations from Quest Diagnostics

  • Human genome sequencing work to help personalize disease management
  • First H1N1 test from a commercial US lab
  • ColoVantage®-first plasma-based methylation diagnostic test for colorectal cancer detection
  • Genetics-based testing, such as BRCAvantage™ for breast and ovarian cancer 
 

 

Female scientist pipetting DNA samples for testingOffer the broadest test menu

The health of your members depends on diagnosing disease to inform the right interventions. We offer an extensive menu of tests that range from routine to highly specialized genetic and molecular tests. Visit our test center to see our wide range of innovative testing.

 

 

 

Powering Innovation with Pioneering Research

Our collaborations with top academic and research institutions lead to earlier risk identification and lower long-term costs. Our partners include: 

  • University of California, San Francisco Precision Diagnostics Alliance
  • Memorial Sloan Kettering Cancer Center Solid Tumor Genomics Alliance
  • Scripps Atrial Fibrillation Genetics and Wireless Monitoring
  • Brigham and Women’s Hospital JUPITER Study, Ion Mobility and VITAL